©Author(s) (or their employer(s)) 2026.
World J Psychiatry. Mar 19, 2026; 16(3): 111523
Published online Mar 19, 2026. doi: 10.5498/wjp.v16.i3.111523
Published online Mar 19, 2026. doi: 10.5498/wjp.v16.i3.111523
Table 1 Demographics and disease characteristics of 101 outpatients with Crohn’s disease, mean ± SD/median (interquartile ranges)
| Characteristic | Value |
| Age in years | 38.2 (13.2) |
| Male, % | 57.9 |
| Educational status, % | |
| Illiterate | 1.5 |
| Basic | 46.2 |
| Secondary | 20 |
| Technical/university degree | 32.3 |
| HBI | 1 (1–3) |
| Smoker, % | 40.8 |
| Montreal classification, % | |
| A1/A2/A31 | 8.5/70.7/20.7 |
| B1/B2/B32 | 51.3/38.5/10.3 |
| L1/L2/L3/L43 | 43.6/10.3/46.2 |
| P value | 28.4 |
| Under biologic treatment, % | 72 |
| Hemoglobin in g/dL | 13.4 (1.8) |
| Anemia, % | 10.3 |
| CRP in mg/L | 0.8 (0.3–2.7) |
| History of Crohn’s-related surgery, % | 34.7 |
| Extra-intestinal manifestations, % | 39.4 |
Table 2 Linear regression analysis of factors associated with higher Depression Anxiety Stress Scale 21 stress scores in patients with Crohn’s disease
| Stress | Univariate | Multivariate | ||
| β (95%CI) | P value | β (95%CI) | P value | |
| Female | 4.5 (1.5 to 7.5) | 0.003 | -8.7 (-20.5 to 3.2) | 0.145 |
| HBI | 1.2 (0.1 to 2.2) | 0.03 | 1.7 (-1.5 to 4.9) | 0.281 |
| HGB | -1.6 (-3 to -0.2) | 0.022 | -4.1 (-7.6 to -0.6) | 0.023 |
| Smoking | 6.9 (2.5 to 11.3) | 0.003 | 9.5 (3.1 to 18.4) | 0.008 |
| A Montreal1 | ||||
| A1 | Reference | |||
| A2 | 4.0 (-2.0 to 9.9) | 0.239 | -3.7 (-15.9 to 8.6) | 0.541 |
| A3 | 7.7 (1.2 to 14.2) | 0.014 | 8.5 (-4.2 to 21.3) | 0.181 |
Table 3 Linear regression analysis of factors associated with higher Depression Anxiety Stress Scale 21 anxiety scores in patients with Crohn’s disease
| Anxiety | Univariate | Multivariate | ||
| β (95%CI) | P value | β (95%CI) | P value | |
| Female | 3.8 (1.5-6.1) | 0.001 | 4.2 (-0.3 to 10.5) | 0.065 |
| HBI | 1.7 (0.8-2.5) | < 0.001 | 2.3 (0.9-3.8) | 0.002 |
| Smoking | 5.0 (1.3-8.7) | 0.008 | 5.9 (1.4-10.5) | 0.012 |
| A Montreal1 | ||||
| A1 | Reference | |||
| A2 | 2.2 (-2.7 to 7.0) | 0.380 | -5.6 (-13.7 to 2.4) | 0.164 |
| A3 | 4.6 (-0.8 to 9.9) | 0.092 | -0.5 (-8.9 to 8.0) | 0.913 |
| L Montreal2 | ||||
| L1 | Reference | |||
| L2 | 1.5 (-3 to 5.9) | 0.515 | -0.3 (-6.8 to 7.4) | 0.933 |
| L3 | 3.4 (0.5-6.4) | 0.024 | 4.9 (0.1-9.7) | 0.046 |
Table 4 Linear regression analysis of factors associated with higher Depression Anxiety Stress Scale 21 depression scores in patients with Crohn’s disease
| Depression | Univariate | Multivariate | ||
| β (95%CI) | P value | β (95%CI) | P value | |
| Female | 3.7 (0.7-6.7) | 0.016 | -5.2 (-19.0 to 8.6) | 0.447 |
| Age | 0.2 (0.0-0.3) | 0.011 | -0.2 (-0.8 to 0.4) | 0.491 |
| HBI | 1.1 (0.1-2.2) | 0.039 | 1.8 (-1.8 to 5.4) | 0.323 |
| HGB | -1.6 (-3.0 to -0.2) | 0.030 | -5.1 (-9.6 to -0.6) | 0.027 |
| Smoking | 6.1 (1.5-10.6) | 0.010 | 7.9 (-1.1 to 16.8) | 0.084 |
| A Montreal1 | ||||
| A1 | Reference | |||
| A2 | 5 (-1.1 to 11.0) | 0.125 | 6.3 (-11.7 to 24.3) | 0.477 |
| A3 | 10.1 (3.5-16.7) | 0.003 | 21.3 (-6.9 to 49.5) | 0.132 |
- Citation: Laoudi E, Papalouka D, Kokkotis G, Gkizis M, Mantzou A, Lyrakos G, Markopoulos P, Prapa P, Voulgaris T, Vlachogiannakos J, Papaconstantinou I, Bamias G. Hypothalamic-pituitary-adrenal dysregulation and psychological distress in Crohn’s disease: Insights from acute and chronic stress responses. World J Psychiatry 2026; 16(3): 111523
- URL: https://www.wjgnet.com/2220-3206/full/v16/i3/111523.htm
- DOI: https://dx.doi.org/10.5498/wjp.v16.i3.111523
